Study: Babies’ Microbiomes Indifferent to Mode of Delivery

Study of 81 six-week-olds who were born by C-section or vaginal delivery didn’t show differences in the structure or function of their microbiota, despite contrary results from other studies on babies.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, ERNEST FStudies of babies’ microbiomes have suggested that the way a baby is born—either vaginally or via caesarian section—impacts bacterial communities, perhaps with long-term consequences. But in a study published today (January 23) in Nature Medicine, researchers at Texas Children’s Hospital report that, after six weeks of age, they could not distinguish between the microbiomes of babies born one way or the other.

“It is incredibly important to answer this question accurately, not only because more than 1 million babies a year are born via cesarean section, but also because any future interventions aimed at correcting or mediating an altered microbiome of cesarean born babies needs to be targeted to the correct window of time,” said coauthor Kjersti Aagaard, in a press release. “We perform cesarean deliveries every day for really good reasons, and we need to be cautious that we do not assign risk to the wrong source, or misattribute risk to a surgery itself rather than the underlying reason that the surgery was undertaken.”

Indeed, some parents have taken to “seeding” their babies with the mothers’ vaginal microbes after a C-section, a practice some health care ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies